Furthermore, select immunogenic modulators also upregulate mannose-6-phosphate receptors (M6PR) on the tumor cell surface, which augment cell membrane permeability to granzyme B produced by activated NK cells and CTLs [48,49]. This evidence concerns the gene M6PR and neoplasm.